Zimmer Biomet HLDS CVR
13F holders, Q2 2026 (June 30)2holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Zimmer Biomet HLDS CVR in their 13F filings, up 1 from Q1 2026. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($0) and GAMMA Investing LLC ($0).
- Company
- Zimmer Biomet HLDS CVR
- Filed as
- PARAGON 28 INC COM CVR from 69913P105 (Q2 2026)
- CUSIP
- 609CVR022
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 501 shares bought, net +501 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 67,326 | $0 |
| GAMMA Investing LLC | 0.00% | New | 501 | $0 |
"% of holder's portfolio" is ZIMMER BIOMET HLDS CVR's weight in each manager's 13F, not the share of Zimmer Biomet HLDS CVR the manager owns.